Literature DB >> 22790074

Prevention of cardiovascular disease after renal transplantation.

My Svensson1, Alan Jardine, Bengt Fellström, Hallvard Holdaas.   

Abstract

PURPOSE OF REVIEW: After renal transplantation, cardiovascular disease (CVD) is the leading cause of death with a functioning graft. Guidelines for prevention of CVD are mainly based on data from the general population. The purpose of this review is to give a practical approach on prevention of CVD in renal transplant recipients. RECENT
FINDINGS: New epidemiological data have shown that in addition to traditional risk factors for CVD, other risk factors may influence cardiovascular risk in renal transplant recipients. Recently, a specific risk calculator for CVD in renal transplant recipients has been developed. Prevention of CVD in renal transplant recipients should include lifestyle modifications, such as prevention of overweight, smoking cessation and physical exercise. Optimal treatment of hypertension, lipid disturbances and posttransplant diabetes should be encouraged. Accumulating evidence indicates that declining graft function and graft loss are potentially modifiable risk factors in this population, which make strategies for preserving graft function important. This situation may include individual tailoring of immunosuppression and use of new immunosuppressive medications with a more favorable effect on cardiovascular risk factors and graft function.
SUMMARY: To prevent CVD in renal transplant recipients, cardiovascular risk assessment should be performed regularly. Prevention should include both lifestyle modifications, optimal treatment of cardiovascular risk factors and strategies to preserve graft function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790074     DOI: 10.1097/MOT.0b013e3283560a3b

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  11 in total

Review 1.  Active targeted delivery of immune therapeutics to lymph nodes.

Authors:  Baharak Bahmani; Ishaan Vohra; Nazila Kamaly; Reza Abdi
Journal:  Curr Opin Organ Transplant       Date:  2018-02       Impact factor: 2.640

Review 2.  Immunosuppressant utilization and cardiovascular complications among Chinese patients after kidney transplantation: a systematic review and analysis.

Authors:  Yan Liu; Mao-Sheng Yang; Jian-Yong Yuan
Journal:  Int Urol Nephrol       Date:  2012-10-11       Impact factor: 2.370

3.  Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients.

Authors:  Guan-Jin Ho; Ming-Che Lee; Chung-Jen Lee; Yen-Cheng Chen; Bang-Gee Hsu
Journal:  Clin Exp Nephrol       Date:  2014-07-19       Impact factor: 2.801

4.  Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients.

Authors:  Colin R Lenihan; Maria E Montez-Rath; Wolfgang C Winkelmayer; Tara I Chang
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

5.  Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis.

Authors:  Kun Zhang; Baoshan Gao; Yuantao Wang; Gang Wang; Weigang Wang; Yaxiang Zhu; Liyu Yao; Yiming Gu; Mo Chen; Honglan Zhou; Yaowen Fu
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

6.  Active video gaming in patients with renal transplant: a pilot study.

Authors:  Dorothy Wei Yun Wang; Laura L Sills; Sara B MacDonald; Ziv Maianski; Ian Alwayn
Journal:  Transplant Res       Date:  2014-08-09

7.  Incidence of cardiovascular events and associated risk factors in kidney transplant patients: a competing risks survival analysis.

Authors:  María Teresa Seoane-Pillado; Salvador Pita-Fernández; Francisco Valdés-Cañedo; Rocio Seijo-Bestilleiro; Sonia Pértega-Díaz; Constantino Fernández-Rivera; Ángel Alonso-Hernández; Cristina González-Martín; Vanesa Balboa-Barreiro
Journal:  BMC Cardiovasc Disord       Date:  2017-03-07       Impact factor: 2.298

8.  Longitudinal Analysis of Cardiovascular Risk Factors in Active and Sedentary Kidney Transplant Recipients.

Authors:  Valentina Totti; Bo Fernhall; Rocco Di Michele; Paola Todeschini; Gaetano La Manna; Maria Cappuccilli; Maria Laura Angelini; Marco De Fabritiis; Franco Merni; Enrico Benedetti; Giulio Sergio Roi; Alessandro Nanni Costa; Giovanni Mosconi
Journal:  Medicina (Kaunas)       Date:  2020-04-16       Impact factor: 2.430

9.  Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern: Meta-analysis and systematic review.

Authors:  Jayant Kumar; Isabella Reccia; Francesco Virdis; Mauro Podda; Ajay Kumar Sharma; Ahmed Halawa
Journal:  World J Transplant       Date:  2021-03-18

Review 10.  Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients.

Authors:  J R Bank; T J Rabelink; J W de Fijter; M E J Reinders
Journal:  J Immunol Res       Date:  2015-07-15       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.